Summary.-The mean nuclear diameter of 100 breast cancers was measured on tissue sections, to evaluate its importance for early prognosis. The cases were subdivided into 3 subgroups: small (25.5% of cases), medium (63.3%) and large (112%) nuclei. Early recurrence and mortality rates were investigated in each of the categories. Increasing nuclear size was shown to be related to mortality from metastatic disease. However, large-nucleus tumours had an inverse relationship with lymphnode involvement and possibly with recurrence rate. Hence, in our material nuclear size as a sole criterion was not a good indicator of the early behaviour of operable breast cancer.
Summary.-The mean nuclear diameter of 100 breast cancers was measured on tissue sections, to evaluate its importance for early prognosis. The cases were subdivided into 3 subgroups: small (25.5% of cases), medium (63.3%) and large (112%) nuclei. Early recurrence and mortality rates were investigated in each of the categories. Increasing nuclear size was shown to be related to mortality from metastatic disease. However, large-nucleus tumours had an inverse relationship with lymphnode involvement and possibly with recurrence rate. Hence, in our material nuclear size as a sole criterion was not a good indicator of the early behaviour of operable breast cancer. SEEKING A VALUABLE DISCRIMINANT, able to contribute to the identification of breast-cancer patients who could take advantage of a more appropriate treatment, is of major concern at present. In the past, attention has been drawn primarily to long-term retrospective prognostic studies, related to various types of surgical and radiotherapeutic schedules; the debate is continuing. Present workers are more prone to scrutinize what happens during the first months and years after primary treatment (Friedell, 1978) . One of the aims of this new attitude is the selection of patients who could obtain some benefit either from adjuvant chemotherapy and/or early breast reconstruction.
One of these discriminants, the mean nuclear diameter of tumour cells, has been investigated on smears of breast-cancer aspiration-biopsies (Kallenberger et al., 1967; Savino & Koss, 1971; Zajdela et al., 1979) . In a previous report (van Bogaert & de Muylder, 1980) we showed that tissue fixation and processing modify nuclear diameters; hence a comparison with cytological data is feasible only after correction by a factor of 1-55. The present study was carried out to verify in tissue sections a possible link between 3 categories of nuclear size and early prognosis.
MATERIALS AND METHODS
We collected a group of 100 breast carcinomas which had all been operated upon by the same surgeon. All of them had been followed up by this surgeon, together with the radiotherapists of the Louvain Institut des Tumeurs. Two patients were lost from the follow-up and were discarded from the prognostic evaluation. This left 98 cases, most of whom had been treated by a combined radio-surgical treatment. Surgical management consisted of a simple mastectomy with axillary dissection.
At the time of analysis, after a mean observation period of 2-5 years, 31 patients (31-6%) had died, either of generalized metastatic disease (23/98, 23-5%) or with no evidence of recurrence (8/98: 8-1%). Sixty-seven patients (68.4%) were still alive after a median followup of 3-2 years (range, 5 months-8 years): 54 without recurrence (55-1%) and 13 with proven metastatic disease (13-3%).
The tumours were diagnosed and classified according to the criteria used at our institu- Table I shows that the distri nuclear types was comparable in th4
The mean values of the respective pe illustrated in Table I were compa gories of similar studies on aspiration-biopsy smears f 2 series (Table II) Only significant comparisons are indicated. * P < 0 05; ** P < 0 01; *** P < 0-001.
between the nodal status and the subsequent evolution. Actually, 66 7% of the patients with recurrent disease, and 68 2%
of those who died from metastatic generalization belonged to the N+ group. Living subjects without recurrence, and those who died from a cause unrelated to their cancer, had respective incidence of 27-0 and 44.400 lymphnode metastases (Table   III) . Table IV shows, in a somewhat different way, the distribution of the 3 nuclear-size subgroups related to the evolution of the disease. The relationship between nuclear diameters and lymphnode involvement shows a parallelism between increasing diameters from Types 1 to 2 and a rising incidence of metastases, respectively from 32-0-51.6%. However, the lowest incidence of lymphnode metastases (27-3%) was seen in tumours with large nuclei. The only statistical difference which was significant was between Types 2 and 3.
Mortality from disseminated disease (M+) appeared to be related to increasing nuclear size; statistical analysis is indicated on Table IV 
DISCUSSION
To the best of our knowledge few studies have been reported on the prognostic implications of nuclear size in breast cancer. A lot of investigations have been carried out using the nuclear grading system proposed by Black & Speer (1957) or using other nuclear parameters such as nuclear crowding and lobulation (Stenkvist et al., 1979) . Their major drawbacks seem to be their lack of reproducibility and their subjectivity (Freedman et al., 1979; Stenkvist et al., 1979) .
A more objective criterion, said to have prognostic implications, was proposed by Kallenberger et al. (1967) who correlated sex chromatin, DNA content and nuclear size with the evolution of breast cancer. studied survival rates according to nuclear sizes on needleaspirates of 359 breast tumours; increase in nuclear size was associated with decreased survival rate. Both 5-year and 10-year survival rates (93 and 82%) were higher among patients whose smears showed small (<9.5 ,um) or fairly small (9.5-12 [kin) carcinoma nuclei. The lowest rates (67 and 58% respectively) were shown by those with large nuclei ( > 19 ,urn) Ashton et al. (1975) for duct and lobular carcinomas were respectively 7-5 + 1.8 and 6-3 + 0 9 ,um; their mean nuclear sizes were distinctly lower than in our material (10 0 + 1.5 and 7-5 + 1.5 ,um). Concerning prognostic implications, the sole convincing observation in our study was the relationship between increasing nuclear size and mortality from disseminated disease. Our finding is partly in keeping with Friedell's (1978) observation of a relationship between nuclear grade and nodal status, except for the less differentiated (large nuclei) tumours. The author saw a systematic relationship between recurrence and nuelear grade, which was not apparent in our study. Antoniades & Spector (1979) reported a correlation between estrogen-receptor (ER) values and cellularity, cell and nuclear sizes. ER+ tumours had a mean nuclear diameter of 9-7 ,um, ER-cancers had a much larger, 11-1 um diameter. Silvestrini et al. (1979) found an inverse relationship between ER and proliferative activity; differentiated tumours had a low DNA-labelling index and high levels of ER. Finally, Hahnel et al. (1979) demonstrated that ER+ cancers had a significantly better chance of survival, and delayed recurrence even in N+ cases.
Concurrent morphological and functional data in the literature indicate a biological relationship between nuclear size, morphofunctional differentiation of breast tumours, and their invasiveness. In our preliminary findings there was a significant increase in mortality from disseminated breast cancer, which paralleled rising nuclear diameters. Other parameters of behaviour were less clearly influenced by this factor. The particular behaviour of large-nucleus tumours might be due to the small number of cases. Moreover, more than one discriminant is probably needed to identify more accurately the patients at risk of early recurrence.
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